コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 o chips manufactured with the fat substitute olestra).
2 fat and 20% of the total energy replaced by olestra.
3 replacing conventional triacylglycerol with olestra.
4 ore and after the nationwide introduction of olestra.
5 eloped in three versions: fat-free, fat-free+olestra (33.3 g olestra), and high-fat (33.3 g fat) (923
6 tigate the effects of covert substitution of olestra, a non-energy-containing fat replacer, for conve
8 examined whether use of the fat substitute, olestra, affect energy balance by comparing the effects
9 ng that experience with the chips containing olestra affected the ability to predict high calories ba
11 e studied during two 14-d treatment periods (olestra and placebo), with a 7-d washout between feeding
12 was no difference in satiety scores between olestra and TG chips (5.7 vs 5.9 on a 9-point scale; P=.
14 so (difference in symptom frequency between olestra and TG, -1.8; 95% confidence interval, -6.2 to 2
15 versions: fat-free, fat-free+olestra (33.3 g olestra), and high-fat (33.3 g fat) (923900 and 2150 kJ
16 352, 3464, and 4457 kJ in control, fat-free, olestra, and high-fat soup conditions, respectively).
20 s (60 vs 77 g [2.1 vs 2.7 oz]; P<.001), with olestra chips receiving lower taste scores (5.6 vs 6.4 o
22 calorie chips and the low-calorie chips with olestra compared to rats that consumed consuming only th
24 to examine whether customary consumption of olestra-containing savory snacks was associated with cha
25 his study showed that substituting fat-free (olestra-containing) potato chips for regular-fat chips c
28 ired to consume core foods providing 20-35 g olestra (depending on estimated energy needs) or the sam
29 Over a 2-wk period, covert substitution of olestra for conventional fat led to reductions in dietar
30 ported by 619 of 1620 (38.2%) persons in the olestra group and 576 of 1561 (36.9%) controls (differen
31 s were reported was that participants in the olestra group had 1 more symptom-day of more frequent bo
35 fected when the nonabsorbable fat substitute olestra is used to uncouple the sensory properties of fa
36 ance because preapproval studies showed that olestra may lower circulating concentrations of fat-solu
43 8% lower and fat intake 11% lower during the olestra period than during the placebo treatment period
46 demonstrates that ad libitum consumption of olestra potato chips during 1 sitting is not associated
48 n multivariate-adjusted models that examined olestra's association with the specified serum nutrients
50 0.05), but energy intake in the fat-free and olestra-soup conditions was not significantly different
51 ompletely for the energy in the fat-free and olestra soups but not for the energy in the high-fat sou
52 dministration approval of the fat substitute olestra (sucrose polyester) called for active postmarket
53 d diet (one-third of dietary fat replaced by olestra to achieve a diet containing 25% metabolizable f
54 mpared with no intake, the top 2 tertiles of olestra use in adults were associated with circulating c
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。